1. Noninvasive Assay for Donor Fraction of Cell-Free DNA in Pediatric Heart Transplant Recipients
- Author
-
Donna K. Mahnke, Huan Ling Liang, Pippa Simpson, Steven Zangwill, Aoy Tomita-Mitchell, William S. Ragalie, Ronit Katz, Karl Stamm, Steven J. Kindel, and Michael E. Mitchell
- Subjects
Graft Rejection ,Pathology ,medicine.medical_specialty ,business.industry ,Myocardium ,030204 cardiovascular system & hematology ,030230 surgery ,Pediatrics ,Endomyocardial biopsy ,03 medical and health sciences ,chemistry.chemical_compound ,surgical procedures, operative ,0302 clinical medicine ,Text mining ,Cell-free fetal DNA ,chemistry ,Population Surveillance ,Heart Transplantation ,Humans ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,Cell-Free Nucleic Acids ,DNA - Abstract
There is a compelling clinical need for a noninvasive alternative to endomyocardial biopsy (EMB) for the surveillance of rejection in heart transplant recipients. We and others have reported on donor cell-free deoxyribonucleic acid (cfDNA), which is shed from the donor allograft and is elevated
- Published
- 2018
- Full Text
- View/download PDF